BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27873483)

  • 1. Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient.
    Khan B; Singer LG; Lilly LB; Chaparro C; Martinu T; Juvet S; Pipkin M; Waddell TK; Keshavjee S; Humar A; Cypel M
    Am J Transplant; 2017 Apr; 17(4):1129-1131. PubMed ID: 27873483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated impact of hepatitis C-positive lung donor utilization on US donor lung supply.
    Mooney JJ; Purington N; Mohabir P; Dhillon GS
    Am J Transplant; 2020 Jan; 20(1):289-297. PubMed ID: 31394016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
    Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
    Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
    Aqel B; Wijarnpreecha K; Pungpapong S; Taner CB; Reddy K; Leise M; Mi L; Dickson RC
    J Hepatol; 2021 Apr; 74(4):873-880. PubMed ID: 33188903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.
    Molnar MZ; Nair S; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Podila PSB; Mas V; Maluf D; Helmick RA; Campos L; Nezakatgoo N; Eymard C; Horton P; Verma R; Jenkins AH; Handley CR; Snyder HS; Cummings C; Agbim UA; Maliakkal B; Satapathy SK; Eason JD
    Am J Transplant; 2019 Nov; 19(11):3046-3057. PubMed ID: 31306549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.
    Suryaprasad A; Basavaraju SV; Hocevar SN; Theodoropoulos N; Zuckerman RA; Hayden T; Forbi JC; Pegues D; Levine M; Martin SI; Kuehnert MJ; Blumberg EA;
    Am J Transplant; 2015 Jul; 15(7):1827-35. PubMed ID: 25943299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017.
    Bixler D; Annambholta P; Abara WE; Collier MG; Jones J; Mixson-Hayden T; Basavaraju SV; Ramachandran S; Kamili S; Moorman A
    Am J Transplant; 2019 Sep; 19(9):2570-2582. PubMed ID: 30861300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes.
    Axelrod DA; Schnitzler MA; Alhamad T; Gordon F; Bloom RD; Hess GP; Xiao H; Nazzal M; Segev DL; Dharnidharka VR; Naik AS; Lam NN; Ouseph R; Kasiske BL; Durand CM; Lentine KL
    Am J Transplant; 2018 Oct; 18(10):2473-2482. PubMed ID: 29701909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.
    Bowring MG; Kucirka LM; Massie AB; Luo X; Cameron A; Sulkowski M; Rakestraw K; Gurakar A; Kuo I; Segev DL; Durand CM
    Am J Transplant; 2017 Feb; 17(2):519-527. PubMed ID: 27456927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding access to transplantation with hepatitis C-positive donors: A new perspective on an old issue.
    Kling CE; Limaye AP; Landis CS; Sibulesky L
    Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28130837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.
    Ting PS; Hamilton JP; Gurakar A; Urrunaga NH; Ma M; Glorioso J; King E; Toman LP; Wesson R; Garonzik-Wang J; Ottmann S; Philosophe B; Sulkowski M; Cameron AM; Durand CM; Chen PH
    Transpl Infect Dis; 2019 Dec; 21(6):e13194. PubMed ID: 31609520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
    de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
    Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients.
    Zhu Y; Shudo Y; Lee R; Woo YJ
    Ann Transplant; 2020 Jun; 25():e922723. PubMed ID: 32527989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Treatment of a Hepatitis C-Positive Patient Who Received Kidney Transplant From a Hepatitis C-Positive Donor: A Case Report.
    Papayannis I; Patel P
    Prog Transplant; 2016 Sep; 26(3):238-40. PubMed ID: 27597771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ.
    Porrett PM; Reese PP; Holzmayer V; Coller KE; Kuhns M; Van Deerlin VM; Gentile C; Smith JR; Sicilia A; Woodards A; McLean R; Abt P; Bloom RD; Reddy KR; Blumberg E; Cloherty G; Goldberg D
    Am J Transplant; 2019 Sep; 19(9):2525-2532. PubMed ID: 31066215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.